Page 22 - OHKF_Biotech_EN
P. 22

2
      •
                 | Shenzhen: Government support with                          Biotech development a government priority
       The Competitive Edge of the HK-SZ Biotech Development and the Significance of the Co-operation
                   mature supply chain                                        To foster biotech development and establish a world-class
                                                                              biomedical industrial cluster, the Shenzhen Municipal Government
                 As the nation’s first city of innovation, and the first municipality to be   in early 2020 published a set of “1+3” documents,  with the clear
                                                                                                                       11
                 designated a national self-dependent innovation demonstration area,   goal of establishing a “one-core, multicentre” cluster comprised of
                 Shenzhen has a strong foundation to foster biotech development. In   the five specialised parks of the Pingshan National Biological
                 addition, I&T development is a priority for the municipality, with its total   Industry Base, Shenzhen-Hong Kong Innovative Policy Exploration
                 R&D investment ranking third nationally at 132.8 billions RMB in 2019,   Area for Biomedicine, Guangming Biomedical Engineering
                 or second nationally in terms of percentage of GDP spent (4.9%).


                 Figure 4    Signature parks of the biomedical industry in the Shenzhen Municipality

                                                                      Baolong
                             Guangming                         Baolong Pilot Zone for Innovation
                       Guangming Biomedical Engineering        and Development of Biomedicine
                        Innovation Demonstration Area             (500,000 square metres)   Pingshan
                          (260,000 square metres)                                         National Biological
                                                                                            Industry Base
                                                                                        (3,290,000 square metres)
                                                                                                          Baguan
                                                                                                   Baguang International Bio Valley
                                                                                                 Pioneering Area for Precision Medicine
                                                                                                    (1,310,000 square metres)






                                                              Loop
                                                   Shenzhen-Hong Kong Innovative Policy
                                                     Exploration Area for Biomedicine
                                                       (1,350,000 square metres)

                 11   “Guiding Opinions on Fostering Development of the Biomedical Industrial Cluster in the Shenzhen Municipality” (《 深圳市促進生物醫藥產業集聚發展的指導意見》) and three associated
                   documents including “Implementation Plan of the Development of the Biomedical Industrial Cluster in the Shenzhen Municipality (2020–2025)” (《深圳市生物醫藥產業集聚發展實施方案
                  (2020–2025年)》), “Action Plan for the Development of the Biomedical Industry in the Shenzhen Municipality (2020-2025)” (《深圳市生物醫藥產業發展行動計劃(2020–2025年)》) and
                   “Measures to Foster Development of the Biomedical Industrial Cluster in the Shenzhen Municipality” (《深圳市促進生物醫藥產業集聚發展的若干措施》).
     20
   17   18   19   20   21   22   23   24   25   26   27